Stockwatch: Pfizer, Roche, AZ, Novo Prolong Pharmaceutical Winter

 
• By Andy Smith

Lackluster reports from Pfizer, Roche, AstraZeneca and Novo Nordisk in a second week of earnings season pervaded by below consensus 2017 guidance followed a first week punctuated by missed sales estimates. So much bad news hanging over the sector feels like a nuclear winter.

Stockwatch_1200x675
Andy Smith gives an investor's perspective on industry news

More from Earnings

More from Business